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Background: Frailty is a condition characterized by a decline in physical function and functional capacity. Common
symptoms of frailty, such as weakness and exhaustion, are prevalent in patients with chronic kidney disease (CKD).
The increased vulnerability of frail patients with coexisting CKD may place them at a heightened risk of
encountering additional health complications. The purpose of this systematic review was to explore the link
between frailty, CKD and clinical outcomes.
Methods: We searched for cross sectional and prospective studies in the general population and in the CKD
population indexed in EMBASE, Pubmed, Web of Science, CINAHL, Cochrane and Ageline examining the association
between frailty and CKD and those relating frailty in patients with CKD to clinical outcomes.
Results: We screened 5,066 abstracts and retrieved 108 studies for full text review. We identified 7 studies associating
frailty or physical function to CKD. From the 7 studies, we identified only two studies that related frailty in patients
with CKD to a clinical outcome. CKD was consistently associated with increasing frailty or reduced physical function
[odds ratios (OR) 1.30 to 3.12]. In patients with CKD, frailty was associated with a greater than two-fold higher risk of
dialysis and/or death [OR from 2.0 to 5.88].
Conclusions: CKD is associated with a higher risk of frailty or diminished physical function. Furthermore, the
presence of frailty in patients with CKD may lead to a higher risk of mortality. Further research must be conducted to
understand the mechanisms of frailty in CKD and to confirm its association with clinical outcomes.
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Chronic kidney disease (CKD) is a major public health
problem affecting an estimated 1.2 million Canadians [1].
Although the overall prevalence of CKD is roughly 10% in
the general population, the disease increases with age,
affecting more than one third of all individuals over age 65
[2]. In this population, CKD is associated with additional
comorbid conditions; a higher risk of cardiovascular dis-
ease and increasing prevalence of frailty and disability [3,4].
Frailty is a multidimensional syndrome characterized
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reproduction in any medium, provided the ordecreased endurance, leading to reduced activity and a
poor response to stressors [5]. Reduced activity in turn
worsens sarcopenia and weakness, causing a downward
functional spiral and increasing risk of death. This is
often exacerbated by social isolation and depression that
reinforces behaviors leading to further inactivity, disuse
and loss of function [6]. Indeed, several prospective studies
have shown that measures of frailty are strongly associated
with death and hospitalization in older individuals and
moreover that this association is independent of other clin-
ical risk factors and comorbid conditions [7].
The interrelationship between frailty, chronic diseases
and adverse outcomes in older people has been recog-
nized as an important focus of research in patients with
cardiovascular disease (CVD) and in patients on dialysisLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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CKD are limited. This is a significant omission given that
CKD correlates with increasing age thereby afflicting a
similar demographic as frailty [5]. Many of the physio-
logical changes resulting from CKD are altered mineral
metabolism, chronic inflammation and arteriosclerosis.
These physiological changes directly or indirectly influ-
ence sarcopenia and weakness, which are core domains of
the frailty construct [10]. Conversely, frailty may adversely
affect adaptations to the numerous health state transitions
that CKD patients undergo over time. As such, individuals
with coexisting frailty and CKD may be at a synergistic
risk of experiencing adverse clinical outcomes. Given that
frailty may be modifiable using readily available interven-
tions, the study of frailty in the patient with CKD seems
particularly important [11].
In order to identify the gaps in evidence in this popula-
tion, we performed a systematic review to identify all rele-
vant studies examining the association between frailty,
physical function and CKD. We hypothesized that patients
with CKD are more likely to be characterized as frail or
functionally limited, and that the coexistence of the two
conditions confers a higher likelihood of adverse clinical
outcomes.
Methods
Search strategy and selection criteria
We aimed to identify observational studies of humans
that explored the link between frailty, CKD, and clinical
outcomes. The primary question of interest was the as-
sociation between frailty and CKD and the likelihood of
adverse clinical outcomes in frail subjects with CKD not
currently on dialysis therapy. The selection criterion was
broadened to include studies that looked at individual
domains of frailty, such as functional limitation.
Data sources and search strategy
In collaboration with a medical librarian (K.M.), a search
strategy was designed and implemented to capture all
relevant studies from the available literature. The follow-
ing electronic databases were searched from their date
of establishment to March 2013: EMBASE, PubMed,
Web of Science (WOS), CINAHL, Cochrane Database of
Systematic Reviews (CDSR), Database of Abstracts of
Reviews of Effects (DARE), Cochrane Central Register of
Controlled Trials (CENTRAL), and AgeLine. The search
strategy was tailored to each database and used a com-
bination of key words such as “frailty,” “elderly,” and
“kidney disease,” as well as MeSH terms (see Additional
file 1: Appendix 1).
Article eligibility criteria
The eligibility for full text review of each citation was in-
dependently evaluated by two reviewers (S.W. and K.G.)on the basis of title and abstract. Any article that was
deemed potentially relevant by either reviewer was re-
trieved for full-text review. The reference lists of any
relevant review articles were also screened to identify
studies which may have potentially been missed in the
search. The reviewers then independently assessed the
full text articles and studies were finalized for inclu-
sion in the systematic review after discussion with a
third reviewer (N.T.). Disagreements were resolved by
consensus.
Data extraction
A data extraction form was created to capture relevant
information from included studies. One reviewer (S.W.)
independently conducted the extraction with verification
by a second reviewer (K.G.). The following informa-
tion was extracted for each study: 1. study characteris-
tics, such as the year of publication, study design, study
population, and sample size; 2. definitions of CKD and
frailty (or its associated domains); and 3. patient character-
istics, such as mean age, percentage of males, race and
comorbidities.
Evaluation of risk of bias
We evaluated each study for risk of bias using the
Newcastle-Ottawa Scale (NOS) [12] in order to assess
its quality. The NOS is a quality evaluation method for
non-randomized studies. The NOS criteria are split into
three sections: Selection, Comparability and Outcome.
Each study is designated a number of stars for each sec-
tion, based on predetermined queries. The queries used
in this systematic review can be found in Additional file 1:
Appendix 2.
Statistical analysis
As significant clinical heterogeneity in the patient popu-
lation, definitions of frailty, study methodologies and co-
variate adjustment were encountered; meta-analysis was
not performed. In order to assess publication bias, we
created funnel plots of the risk associations (Additional
file 1: Appendix 3). Cross-sectional and Cohort studies
were plotted separately.
Declaration of sources of funding
No specific funding.
Results
Search results and study selection
The search retrieved 5,066 individual citations for screen-
ing. After conducting the initial screen of these citations,
108 articles were selected for full-text review and of
these, 7 articles met criteria for inclusion in the study.
The basis of exclusion for the remaining articles is shown
in Figure 1 [13].
Records excluded
(n = 4958)





3: Not in English
26: Review
31: No Frailty Measurement
41: No CKD Outcomes





Figure 1 Flow Diagram of Reviewed Studies.
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The 7 included studies encompassed a total of 20,332
patients. All 7 studies examined the relationship between
CKD and frailty (or one its domains), but only two stud-
ies related frailty in CKD patients to a clinical outcome
[14,15]. The studies were mainly conducted in the United
States and published after 2004 with the exception of one
conducted in Italy, published in 2012 [16]. Two of the
studies were prospective [4,15] and the remaining studies
were secondary analyses [14,16-19]. All of the studies
provided a measure of kidney function and a description
of frailty or one of its domains. Table 1 shows the individ-
ual study characteristics for the included studies.
Measures of frailty and physical function
Each study used different methods for the definition and
identification of frailty and physical function (Table 2).
Both of the studies examining the association between
frailty and adverse clinical outcomes relied on a modified
version of the Fried frailty criteria. Wilhelm-Leen et al.
abbreviated multiple measures and relied on single item
questions to define the weakness, exhaustion and phys-
ical activity domains of the frailty definition. In contrast,
Roshanravan et al. used objective criteria for weakness,
but defined exhaustion from the results of a survey (SF-36)
and slowness from the results of a 4 meter walk test.
The studies examining an association between frailty
or physical function and CKD used many different defi-
nitions of decreased physical function. One study [18]
used unmodified Fried frailty criteria. Two studies used
standardized measurements to identify reduced physicalability, measuring exercise and functional capacity [17]
and completing a Short Physical Performance Battery [16]
test. Two studies allowed patients to self-report whether
they were functionally limited [4] or whether they had diffi-
culty with activities of daily living [19]. A detailed descrip-
tion of the frailty/physical function criteria in each study is
listed in Table 2.
Association of frailty with CKD
We found 7 studies that examined the association of frailty
or its individual components with CKD. The largest study
in our analysis utilized data from the third National Health
and Nutrition Evaluation Survey (NHANES III) and exam-
ined the association between frailty as defined by the modi-
fied Fried criteria and CKD defined by serum creatinine
based eGFR [14]. The results suggested that patients in the
early stages of CKD were at a greater than two-fold higher
risk of being frail in comparison to healthy patients [CKD
stage 1/2: odds ratio (OR) 2.21, 95% confidence interval
(CI) 1.49-3.28; CKD stage 3a: OR 2.48, 95% CI 1.57-3.93].
Furthermore, patients with CKD at or beyond stage 3b
were found to be nearly six times as likely to be frail (OR
5.88, 95% CI 3.40-10.16). A similar community based
study, using the Cardiovascular Health Study population,
also found consistent results, but the association was
weaker (OR 1.76, 95% CI 1.28-2.41 [18]. Finally, a more re-
cent study [15] , in the advanced CKD population, also
showed similar findings. In this population, patients with
and eGFR in the range of 30–44 mL/min/1.73 m2 were two
times more likely to have the frailty phenotype (OR 2.1,
95% CI 1.0-4.7) and patients with an eGFR measurement
Table 1 Characteristics of included studies





CKD and frailty associated with outcome
Wilhelm-Leen [14] age ≥20 3–5 frailty domains
measured NHANES III
10,256 Frailty and CKD linked to mortality Modified Fried Frailty
Criteria
Both Chronic Kidney Disease
Stage 5
CKD Stage 5 definition: eGFR
<45 mL /min/1.73 m2
Roshanravan [15] age ≥18 CKD Stages 1–4 not
requiring dialysis
336 Frailty associated with lower eGFR




Both Chronic Kidney Disease CKD definition: eGFR
<90 mL /min/1.73 m2
OR albuminuriab
CKD and frailty associated
Odden [17] previous cardiac event or
disease
954 CKD associated with physical limitation
and reduced exercise capacity
Exercise and Functional
Capacity
Both Chronic Kidney Disease
Stage 3 or higher
CKD Stage 3 definition: Creatinine
clearance <60 ml/min
Shlipak [18] Medicare eligibility age > 65
non-institutionalized
5,808 CRI associated with frailty in
community dwelling elder adults
Fried Frailty Criteria Both Chronic Renal
Insufficiency
CRI definition: Male = serum
creatinine >1.5 mg/dL,
Female = serum creatinine
>1.3 mg/dL
Fried [4] Medicare eligibility age 70–79
no existing functional limitation
2,135 CKD associated with development
of impaired physical function
Functional Limitation Self Kidney Function
Quartile
Cystatin C input to MDRD.
Secondary analysis grouped
patients as eGFR <60 mL /
min/1.73 m2 vs other
Bowling [19] Community-dwelling Medicare
beneficiaries age ≥65
357 CKD associated with functional decline IADLs and BADLs Self Chronic Kidney Disease
Stage 3 or higher
CKD definition: eGFR
<60 mL /min/1.73 m2
Lattanzio [16] Older Hospitalized Patients 486 Reduced kidney function associated
with poor physical performance
Short Physical
Performance Battery
Observer Chronic Kidney Disease
Stage 3 or higher
CKD definition: eGFR
<60 mL /min/1.73 m2
BADL Basic activities of daily living, CKD Chronic Kidney Disease, CRI Chronic Renal Insufficiency, DM diabetes mellitus, eGFR estimated glomerular filtration rate, IADL Instrumental activities of daily living, MDRD Modification of Diet
in Renal Disease equation, NHANES III, third National Health and Nutrition Evaluation Survey, RRT renal replacement therapy.
astudy sample size.



















Table 2 Frailty and physical function criteria
First author, year Physical
measurement
Physical measurement method Outcome Criteria
CKD and frailty associated with outcome
Wilhelm-Leen [14] Modified Fried
Frailty Criteria
• Low body weight (BMI ≤ 18.5 kg/m2) Frailty 3 or more frailty domains present
• Slow walking speed in timed 8 foot walk
(lowest 20% adjusted for gender)
• Self reported weakness
• Self reported exhaustion
• Self reported low physical activity
Roshanravan [15] Modified Fried
Frailty Criteria




Frailty: 3 or more frailty domains
Intermediate Frailty: 1 or 2 frailty
domains present
• Grip Strength (lowest 20% adjusted for
gender and BMI)
• Self reported Exhaustion (lowest 20%
score on SF-36)
• Slow walking speed in timed 15 foot
walk (lowest 20% adjusted for gender
and height)
• Self reported low physical activity
(exercise <1 per week)
CKD and frailty associated
Odden [17] Exercise and
Functional Capacity




Physical Limitation: SAQ score <75
• Objective exercise capacity (treadmill test
evaluated by Bruce protocol)b
Low Exercise Capacity: maximum
exercise capacity <5 MET
Shlipak [18] Fried Frailty Criteria: • Unintentional weight loss (≥ 10 lbs or
≥ 5% loss in body weight)
Frailty 3 or more frailty domains present
• Slow walking speed on 15 foot walk
(lowest 20% adjusted for gender
and height)
• Grip Strength (lowest 20% adjusted for
gender and BMI)
• Poor endurance and energy (CES-D
questionnaire)
• Self reported low physical activity
(lowest 20% adjusted for gender)
Fried [4] Physical Function • Self-reported difficulty in climbing 10
steps or walking one quarter of a mile
Functional Limitation Two consecutive reports of difficulty
involving the same function (stairs or
walking, measured every 6 months)
Bowling [19] Functional Decline • IADL Scorec Functional Limitation IADL or BADL score lower than
baseline values
• BADL Scored
Lattanzio [16] Short Physical
Performance Battery
• Slow walking speed test (scored 0–4) Good, Intermediate or Poor
physical performance
Grouping by SPPB Score: 0–4,
5–8 and 9-12
• Chair stand test(scored 0–4)
• Balance test (scored 0–4)
BADL Basic Activities of Daily Living, BMI body mass index, CES-D Center for Epidemiologic Studies Depression Scale, IADL Instrumental activities of daily living,
MET metabolic equivalent tasks SPPB, Short Physical Performance Battery, SAQ Seattle Angina Questionnaire. SF-36, 36-Item Short Form Health Survey.
aSAQ scored from 0-100, High Score denotes better physical function.
bBruce Protocol: maximum exercise capacity determined by total number of MET achieved in test.
cIADLs list: using the telephone, light housework, heavy housework, preparing meals, shopping and managing money.
dBADL list: bathing, transferring out of a bed or chair, eating, toileting and dressing.
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more likely to be frail (OR 2.8, 95% CI 1.3-6.3).
The remaining four studies largely focused on the
physical function domains of frailty such as functionallimitation, exercise capacity and physical performance in
relation to CKD. One of the four studies used creatinine
clearance as a marker of kidney function. The remaining
three studies utilized eGFR measurements to determine
Table 3 Associations reported within included studies
First author, year Association Analysis
CKD and frailty associated with outcome
Wilhelm-Leen [14] • Mortality in frail patients with CKD HR 2.0, 95% CI 1.5 - 2.7
• Frailty in patients with CKD stage 1/2 OR 2.21, 95% CI 1.49-3.28
• Frailty in patients with CKD stage 3a OR 2.48, 95% CI 1.57-3.93
• Frailty in patients with CKD stage 3b-5 OR 5.88, 95% CI 3.40-10.16
Roshanravan [15] • Frailty components associated with Death or Dialysis HR 2.5, 95% CI 0.9-2.87
• Frailty with eGFR between 30- 44 mL/min/1.73 m2 HR 2.1, 95% CI 1.0-4.7
• Frailty with eGFR <30 mL/min/1.73 m2 HR 2.8, 95% CI 1.3-6.3
CKD and frailty associated
Odden [17] • Physical limitation with creatinine clearance between 60-90 mL/min OR 1.0, 95% CI 0.7-1.5
• Physical limitation with creatinine clearance <60 mL/min OR 2.0, 95% CI 1.3-3.1
• Low exercise capacity with creatinine clearance between 60-90 mL/min OR 2.3, 95% CI 1.4-3.8
• Low exercise capacity with creatinine clearance <60 mL/min OR 6.7, 95% CI 3.8-11.8
Shlipak [18] • Frailty in patients with CRI OR 1.76, 95% CI 1.28-2.41
Fried [4] • Functional limitation in patients with CKD (eGFR <60 mL/min/1.73 m2) HR 1.30, 95% CI 1.08-1.56
Bowling [19] • IADL decline with CKD stage≥3B (eGFR <45 mL/min/1.73 m2) OR 3.12, 95% CI 1.38-7.06
• BADL decline with CKD stage≥3B (eGFR <45 mL/min/1.73 m2) OR 3.78, 95% CI 1.36-9.77
Lattanzio [16] • Low SPPB total score and eGFR B = 0.49, 95% CI 0.18-0.66, p=0.003
BADL Basic Activities of Daily Living, CI confidence interval, CKD Chronic Kidney Disease, CRI chronic renal insufficiency, HR hazard ratio, IADL Instrumental
activities of daily living, OR odds ratio, SPPB Short Physical Performance Battery.
Table 4 Newcastle-Ottawa scale quality evaluation
First author, year Selection Comparability Outcome Total
CKD and frailty associated with outcome
Wilhelm-Leen [14] 3 2 0 5
Roshanravan [15] 2 2 1 5
CKD and frailty associated
Odden [17] 3 2 0 5
Shlipak [18] 3 2 0 5
Fried [4] 4 2 1 7
Bowling [19] 4 1 1 6
Lattanzio [16] 3 2 0 5
Newcastle-Ottawa Scale Quality Criteria can be found in Additional file 1:
Appendix 2.
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ently associated with a higher risk of developing a limita-
tion in the physical function domain of frailty that each
respective study examined. A summary of the associations
between CKD, frailty and/or frailty domains reported by
each of the studies is seen in Table 3.
Association of frailty with clinical outcomes in patients
with CKD
Only two published studies related frailty in patients
with CKD to an adverse clinical outcome [14,15]. One
study used data from NHANES III and related frailty in
patients with CKD to mortality. After adjusting for mul-
tiple comorbid conditions, frailty in CKD patients was
associated with a two-fold higher risk of mortality com-
pared to CKD patients who were not frail [hazard ratio
(HR) 2.0, 95% CI 1.5-2.7]. The second study was per-
formed in a smaller population with more advanced CKD
and used Death and Dialysis as the clinical outcomes. The
study adjusted for age, sex, BMI, eGFR, diabetes and car-
diovascular disease and found that the frailty phenotype
was associated with a 2.5 fold greater risk of death or dialy-
sis therapy (HR 2.5, 95% CI 0.9-2.87).
Risk of bias
The two studies associating Frailty and CKD with clin-
ical outcomes had a similar risk of bias. Both studies has
relatively low risk of bias in selection and comparabilitydomains, but had a higher risk of bias in evaluation of
outcome. The remaining five studies associated frailty or
physical function and CKD and all had a similar risk of
bias. A detailed description of the quality assessment is
described in Table 4.
Discussion
In our systematic review, we found multiple studies con-
firming independent associations between frailty, dimin-
ished physical function and CKD. There was an association
between presence of CKD and being frail or having limita-
tions of physical function. More importantly, in patients
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cause mortality and dialysis after adjusting for multiple co-
morbid conditions. Our findings highlight the importance
of frailty as both a health outcome and an independent
predictor of adverse outcomes in CKD. This has important
implications for the clinical care of these patients and for
the design of epidemiological studies in this population. In
addition, our review also confirms the paucity of literature
examining the relationships between frailty, kidney func-
tion and clinical outcomes.
To our knowledge, our systematic review is the first to
explore frailty and physical function in the CKD popula-
tion. A previous systematic review explored the associ-
ation between frailty and CVD [8]. The study showed
that a possible bidirectional relationship exists between
frailty and CVD and found that frailty in the CVD popu-
lation was a powerful predictor of mortality. The CVD
review was different from ours in that the investigators
adhered to strictly defined frailty criteria when choosing
studies to be included in their review, rather than a
more open-ended definition of frailty and physical func-
tion in our study. In the kidney failure population, a sin-
gle prospective study exploring frailty amongst patients
with end-stage renal disease (ESRD) analyzed data col-
lected in the Dialysis Morbidity and Mortality Study
(DMMS) Wave 2 [9]. Their definition of frailty was similar
to the modified Fried frailty because it incorporated poor
self-reported physical functioning, exhaustion/fatigue, low
physical activity and under-nutrition. They discovered that
nearly two thirds of the examined cohort of dialysis pa-
tients met their definition of frailty. Furthermore, they
found that frailty in patients on dialysis was independently
associated with mortality. In addition, the investigators
conducting this analysis were also able to examine compo-
nents of frailty individually and found that each compo-
nent was independently associated with mortality in
patients with kidney failure.
Two of the seven studies included in our review exam-
ined the association between frailty and clinical out-
comes in patients with CKD, and also studied the
association between prevalent CKD and frailty [14,15].
Both studies defined frailty using modified Fried criteria
and utilized self-reported criteria items to define the ex-
haustion and physical activity domains of frailty. Only
one of the two studies followed the Fried criteria for
weight loss and weakness, the other defined weight loss
as a cross sectional BMI <18.5 and used self-reporting for
weakness measurements [14]. The lack of standardized
definitions for each of the domains, as well as retrospect-
ive adaptation of questionnaires to fit the frailty domains,
limits comparisons between these studies. In fact, recent
studies have shown that defining frailty based on self-
reported questionnaires may lead to significantly higher
perceived prevalence than using measured constructs,and therefore further study of frailty using more objective
measures is needed [20].
Of the remaining five studies in our review, only one
study utilized the Fried frailty criteria. This study [18]
only used self-reported values for exhaustion and low
physical activity measurements. The additional four stud-
ies examined domains of physical ability to study the as-
sociation between physical function and CKD. Two of
these studies used self-reported values to assess ability to
complete activities of daily living [19] and functional
limitation [4] as outcomes. The remaining two studies
used objective measurements to assess physical ability as
exercise and functional capacity [17] or Short Physical
Performance Battery tests [16]. None of the studies in
our review examined alternative definitions of frailty and
most did not assess potentially important domains, in-
cluding mood and cognition. Alternative domains may be
particularly important in patients with CKD, as both cog-
nitive impairment and depressed mood can strongly in-
fluence decision making about dialysis modalities for
both the patient and the provider. Multiple studies in the
kidney failure population have suggested that cognitive
impairment and depression are exceedingly common in
patients with CKD and we believe that future work on
frailty in this population should include study of these
potentially modifiable domains [21,22].
There are several direct clinical and research implica-
tions to our findings. First, the majority of the studies in
our review used questionnaires and physical function tests
that can be easily administered in the inter-professional
CKD clinic setting. If frailty is indeed confirmed to be inde-
pendently associated with adverse outcomes in CKD, these
assessments could be performed routinely in the renal
clinic setting without adding significant resources or pa-
tient burden. In addition, multiple studies have shown that
simple nutritional and physical function interventions such
as nutrition and exercise programs targeted at reducing
frailty can have an impact on important functional out-
comes in the general population and in patients with kid-
ney failure [23-25]. Given that frailty is a modifiable risk
factor in the older general population and the high preva-
lence of older patients in CKD clinics, studies examining
the effects of treating frailty in older patients with CKD are
urgently needed.
There are several strengths of our review. Our search
strategy included multiple electronic databases in an at-
tempt to ensure that all of the published literature examin-
ing frailty and CKD was captured. We manually searched
the bibliographies of the included articles to ensure that we
achieved a high sensitivity of our search strategy. We also
examined the quality of each included study using vali-
dated criteria and highlighted deficiencies in evidence and
reporting. Finally, we broadened our search criteria to in-
clude studies examining any definition of frailty and also
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tion affording the ability to assess the impact of CKD on
individual domains of frailty.
Our study has some limitations. Our review was fo-
cused on the published literature and it is possible that
publication bias may have played a role and excluded
studies showing a lack of association between frailty
and CKD. Although, our funnel plots (Additional file 1:
Appendix 3) did not show any obvious evidence of publi-
cation bias, it is possible that residual bias remains in our
study selection. Secondly, most of the studies included in
our review were secondary data analyses as opposed to
primary prospective studies of frailty in CKD. As such,
these analyses came from studies not directly designed to
explore the link between frailty and CKD, but instead, had
data elements which allowed secondary analyses. Thirdly,
the methods for assessing physical function, physical per-
formance and frailty in the studies included in our review
were heterogeneous. Conclusions about the relationship
between CKD and frailty and/or physical function may be
limited by the lack of comparisons between different
methods in the same population. Finally, we did not in-
clude studies examining frailty in patients undergoing
dialysis or kidney transplant. Although frailty has been
studied more extensively in the kidney failure population,
the physiological alterations and morbidity associated
with dialysis treatments may not be applicable to patients
with CKD not on dialysis.
Conclusion
In conclusion, our systematic review confirms the inde-
pendent association between frailty, CKD and adverse
clinical outcomes. Frailty appears to be independently as-
sociated with prevalent CKD, and the presence of frailty in
CKD may be strongly associated with all-cause mortality.
In addition, our review highlights the paucity of literature
examining the association between CKD and frailty. Fur-
ther studies examining the epidemiology of frailty in
patients with CKD using objective physical and cognitive
function criteria are needed, both to elucidate the under-
lying mechanisms and to inform clinical trials using tar-
geted interventions.
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